<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>8399</billNumber>
    <createDate>2020-09-26T07:12:07Z</createDate>
    <updateDate>2020-12-03T08:15:34Z</updateDate>
    <originChamber>House</originChamber>
    <billType>HR</billType>
    <introducedDate>2020-09-25</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 166, Number 167 (Friday, September 25, 2020)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Ms. FINKENAUER:H.R. 8399.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8, Clause 18 of the UnitedStates Constitution.[Page H4962]</pre>]]></constitutionalAuthorityStatementText>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hswm00</systemCode>
          <name>Ways and Means Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees />
          <activities>
            <item>
              <name>Referred to</name>
              <date>2020-09-25T13:00:20Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>Affordable Medications Act</latestTitle>
        <congress>116</congress>
        <number>1801</number>
        <type>S</type>
        <latestAction>
          <actionDate>2019-06-12</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <latestTitle>End Taxpayer Subsidies for Drug Ads Act</latestTitle>
        <congress>116</congress>
        <number>73</number>
        <type>S</type>
        <latestAction>
          <actionDate>2019-01-10</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-09-25</actionDate>
        <links />
        <text>Referred to the House Committee on Ways and Means.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-09-25</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <item>
        <actionDate>2020-09-25</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>F000467</bioguideId>
        <fullName>Rep. Finkenauer, Abby [D-IA-1]</fullName>
        <firstName>Abby</firstName>
        <middleName />
        <lastName>Finkenauer</lastName>
        <party>D</party>
        <state>IA</state>
        <identifiers>
          <lisID>2394</lisID>
          <bioguideId>F000467</bioguideId>
          <gpoId />
        </identifiers>
        <district>1</district>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S001208</bioguideId>
        <fullName>Rep. Slotkin, Elissa [D-MI-8]</fullName>
        <firstName>Elissa</firstName>
        <middleName />
        <lastName>Slotkin</lastName>
        <party>D</party>
        <state>MI</state>
        <identifiers>
          <lisID>2407</lisID>
          <bioguideId>S001208</bioguideId>
          <gpoId />
        </identifiers>
        <district>8</district>
        <sponsorshipDate>2020-09-25</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <bioguideId>T000483</bioguideId>
        <fullName>Rep. Trone, David J. [D-MD-6]</fullName>
        <firstName>David</firstName>
        <middleName>J.</middleName>
        <lastName>Trone</lastName>
        <party>D</party>
        <state>MD</state>
        <identifiers>
          <lisID>2406</lisID>
          <bioguideId>T000483</bioguideId>
          <gpoId />
        </identifiers>
        <district>6</district>
        <sponsorshipDate>2020-12-02</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates />
    <laws />
    <notes />
    <policyArea>
      <name>Taxation</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Business expenses</name>
          </item>
          <item>
            <name>Income tax deductions</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Taxation</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2020-09-25</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2020-11-02T12:52:33Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>End Taxpayer Subsidies for Drug Ads Act</b></p> <p>This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. </p> <p><i>Direct-to-consumer advertising</i> is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public. </p>]]></text>
          <updateDate>2020-09-25T04:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
      </billSummaries>
    </summaries>
    <title>End Taxpayer Subsidies for Drug Ads Act</title>
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>End Taxpayer Subsidies for Drug Ads Act</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>End Taxpayer Subsidies for Drug Ads Act</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>End Taxpayer Subsidies for Drug Ads Act</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2020-09-25T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr8399ih/xml/BILLS-116hr8399ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-09-25</actionDate>
      <text>Referred to the House Committee on Ways and Means.</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

